Peptide record

TPDB10113

Antibacterial Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10113
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 23-aa standard-residue multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
GICKFLHSAKKFGKAFVGEIMNS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C115H182N30O29S2
RDQPTWY
K
2513.01
10.17
5
1
10
+3
0.40
0.209
72.17
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
4
Residue Composition
number
2
A
0
R
1
N
0
D
1
C
1
E
0
Q
3
G
1
H
2
I
1
L
4
K
1
M
3
F
0
P
2
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 0 C: 1 E: 1 Q: 0 G: 3 H: 1 I: 2 L: 1 K: 4 M: 1 F: 3 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
23 reviewed residue count
C115H182N30O29S2 sequence-only estimate (linear, free termini)
2513.01 sequence-only estimate (linear, free termini)
10.17 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.40 sequence-only estimate (linear, free termini)
0.209 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

9% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
9% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. | J Antimicrob Chemother | 1999